European Biotechs are utilizing AI and precision medicines to improve the personalized treatment of cardiovascular disease.
Background The optimal surgical strategy for mitral valve (MV) infective endocarditis (IE) remains uncertain. Although valve ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results